Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 43.81
Key Takeaways
Risk factor
Very vulnerable to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on
Data is available to registered users only
Buy
Sell